Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease

Phytomedicine

Volumn 19, Issue 5, 2012, Pages 418-423

  Chainani Wu, N ^a,b   Collins, K ^a,c   Silverman Jr , S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Francisco State University ^*

^c SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Adverse effects; Autoimmune; Curcuminoids; Oral lichen planus; Safety

Indexed keywords

CURCUMIN; NON PRESCRIPTION DRUG;

ABDOMINAL DISCOMFORT; ARTICLE; AUTOIMMUNE DISEASE; DEFECATION URGENCY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INTERVIEW; LICHEN PLANUS; MAJOR CLINICAL STUDY; MOUTH DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TABLET FORMULATION; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; COHORT STUDIES; CURCUMIN; DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; LICHEN PLANUS, ORAL; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858080100     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.11.005     Document Type: Article

References (8)

1. N. Chainani-Wu, S. Silverman Jr., F. Lozada-Nur, P. Mayer, and J. Watson Oral lichen planus: patient profile, disease progression and treatment responses Journal of American Dental Association 132 2001 901 909
2. N. Chainani-Wu Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa) The Journal of Alternative and Complementary Medicine 9 2003 161 168 (Pubitemid 36297021)
3. Chainani-Wu, N., Madden, E., Lozada-Nur, F., Silverman, S.Jr., 2011. High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. Journal of The American Academy of Dermatology, Sep 8. [Epub ahead of print] PubMed PMID: 21907450.
4. N. Chainani-Wu, S. Silverman Jr., A. Reingold, A. Bostrom, C. McCulloch, F. Lozada-Nur, and J. Weintraub A randomized, double-blind, placebo-controlled clinical trial of curcuminoids in oral lichen planus Phytomedicine 14 2007 437 446 (Pubitemid 47068956)
5. A.L. Cheng, C.H. Hsu, J.K. Lin, M.M. Hsu, Y.F. Ho, T.S. Shen, J.Y. Ko, J.T. Lin, B.R. Lin, W. Ming-Shiang, H.S. Yu, S.H. Jee, G.S. Chen, T.M. Chen, C.A. Chen, M.K. Lai, Y.S. Pu, M.H. Pan, Y.J. Wang, C.C. Tsai, and C.Y. Hsieh Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Research 21 2001 2895 2900
6. N. Dhillon, B. Aggarwal, R.A. Newman, R.A. Wolff, A.B. Kunnumakkara, J. Abbruzzese, C. Ng, V. Badmaev, and R. Kurzrock Phase II trial of curcumin in patients with advanced pancreatic cancer Clinical Cancer Research 14 14 2008 4491
7. R.A. Sharma, S.A. Euden, S.L. Platton, and D.N. Cooke Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clinical Cancer Research 10 20 2004 6847 6854 (Pubitemid 39383033)
8. G. Shoba, D. Jay, T. Joseph, M. Majeed, R. Rajendran, and P.S.S.R. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Medica 64 1998 353 356 (Pubitemid 28234275)